These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7982642)

  • 41. [Diagnosis and treatment of intrahepatic cholestasis syndrome].
    Kraus MR; Scheurlen M
    MMW Fortschr Med; 2004 Jun; 146(23):34-7. PubMed ID: 15373130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hepatic transplantation for severe ductopenia related to ingestion of thiabendazole].
    Skandrani K; Richardet JP; Duvoux C; Cherqui D; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 1997; 21(8-9):623-5. PubMed ID: 9587501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
    Twaddell WS; Lefkowitch J; Berk PD
    Semin Liver Dis; 2008 Feb; 28(1):128-34. PubMed ID: 18293283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model.
    Dondorf F; Fahrner R; Ardelt M; Patsenker E; Stickel F; Dahmen U; Settmacher U; Rauchfuß F
    World J Gastroenterol; 2017 Jun; 23(23):4191-4199. PubMed ID: 28694659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis.
    Combes B; Markin RS; Wheeler DE; Rubin R; West AB; Mills AS; Eigenbrodt EH; Maddrey WC; Munoz SJ; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White HM; Zetterman RK; Carithers RL
    Hepatology; 1999 Sep; 30(3):602-5. PubMed ID: 10462363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis.
    Guañabens N; Ruiz-Gaspà S; Gifre L; Miquel R; Peris P; Monegal A; Dubrueil M; Arias A; Parés A
    J Bone Miner Res; 2016 Sep; 31(9):1725-33. PubMed ID: 27019303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.
    Oppenheimer AP; Koh C; McLaughlin M; Williamson JC; Norton TD; Laudadio J; Heller T; Kleiner DE; High KP; Morse CG
    World J Gastroenterol; 2013 Jan; 19(1):115-21. PubMed ID: 23326172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histodynamic interpretation of biliary epithelio-mesenchymatous reactions in experimental cholostasis.
    Serrao D; Cardoso V
    Pathol Eur; 1973; 8(3):219-34. PubMed ID: 4272721
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pathophysiology and clinical aspects of intrahepatic cholestasis].
    Kühn HA; Richter E
    Med Klin; 1970 Jan; 65(1):1-8. PubMed ID: 4929317
    [No Abstract]   [Full Text] [Related]  

  • 50. Cloxacillin-induced acute vanishing bile duct syndrome: A case study and literature review.
    Faragalla K; Lau H; Wang HL; Liu J
    Br J Clin Pharmacol; 2022 Oct; 88(10):4633-4638. PubMed ID: 35730139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver histology in benign biliary stricture: fibrosis to cirrhosis . . . and reversal?
    Sikora SS; Srikanth G; Agrawal V; Gupta RK; Kumar A; Saxena R; Kapoor VK
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1879-84. PubMed ID: 19120875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic intrahepatic cholestasis of sarcoidosis.
    Rudzki C; Ishak KG; Zimmerman HJ
    Am J Med; 1975 Sep; 59(3):373-87. PubMed ID: 1163546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement of vanishing bile duct syndrome with hyperlipidemia.
    Yamauchi R; Takata K; Fukunaga A; Tanaka T; Yokoyama K; Shakado S; Nabeshima K; Yoshimitsu K; Hirai F
    Clin J Gastroenterol; 2022 Aug; 15(4):784-790. PubMed ID: 35802301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unilateral cirrhosis: bleeding varices, right hepatic duct diaphragm, and left hepatic duct atresia.
    Goldenberg DA; Brooks WS JrU ; Galambos JT
    Dig Dis Sci; 1981 Sep; 26(9):843-51. PubMed ID: 7285750
    [No Abstract]   [Full Text] [Related]  

  • 55. A case of drug-induced ductopenia resulting in fatal biliary cirrhosis.
    Ishii M; Miyazaki Y; Yamamoto T; Miura M; Ueno Y; Takahashi T; Toyota T
    Liver; 1993 Aug; 13(4):227-31. PubMed ID: 8377599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Vanishing bile duct syndrome following allogeneic bone marrow transplantation].
    Aliani S; Meyer S; Krenn T; Müller-Molaian I; Graf N
    Klin Padiatr; 2002; 214(6):371-4. PubMed ID: 12424687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy.
    Eckstein RP; Dowsett JF; Lunzer MR
    Pathology; 1993 Jul; 25(3):223-8. PubMed ID: 8265236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ongoing cirrhosis after successful porticoenterostomy in infants with biliary atresia.
    Altman RP; Chandra R; Lilly JR
    J Pediatr Surg; 1975 Oct; 10(5):685-91. PubMed ID: 1185455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pathology of primary biliary cirrhosis and autoimmune cholangitis.
    Ludwig J
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):601-13. PubMed ID: 10976017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Clinical Review of Primary Biliary Cholangitis.
    Pullen R
    Gastroenterol Nurs; 2020; 43(2):E48-E55. PubMed ID: 32251226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.